Cover Feature: Amphiphilic Fullerene‐BODIPY Photosensitizers for Targeted Photodynamic Therapy (ChemMedChem 6/2022)

The Cover Feature illustrates the amphiphilic glucose‐BODIPY‐fullerene nanotheranostic carriers as targeting cancer cells via photodynamic therapy (PDT, i.e. the true source of the hero's power). These developed heavy‐atom‐free phototheranostic agents were fabricated with a universal spin conve...

Full description

Saved in:
Bibliographic Details
Published inChemMedChem Vol. 17; no. 6
Main Authors Gündüz, Ezel Öztürk, Gedik, M. Emre, Günaydın, Gürcan, Okutan, Elif
Format Journal Article
LanguageEnglish
Published 18.03.2022
Subjects
BODIPY
fullerene
in vitro
PDT
singlet oxygen
Online AccessGet full text

Cover

More Information
Summary:The Cover Feature illustrates the amphiphilic glucose‐BODIPY‐fullerene nanotheranostic carriers as targeting cancer cells via photodynamic therapy (PDT, i.e. the true source of the hero's power). These developed heavy‐atom‐free phototheranostic agents were fabricated with a universal spin converter, fullerene, a light‐harvesting unit, BODIPY, and an active targeting site, glucose. When irradiated with a red‐light source to disrupt cancer cells, they produced efficient singlet oxygen and proved to be a promising treatment strategy as a fullerene‐mediated PDT approach. Cover design by Dr. Günaydın, Dr. Gedik, and Dr. Okutan. More information can be found in the Research Article by Ezel Öztürk Gündüz, Elif Okutan et al.
ISSN:1860-7179
1860-7187
DOI:10.1002/cmdc.202200117